Controversial new research suggests that doping with recombinant human erythropoietin (EPO) – a behaviour that has brought down many elite cyclists – may not enhance racing performance. The Dutch study published in Lancet Haematology found EPO provided a small benefit in terms of maximal performance in the laboratory that did not translate into an advantage in ...
EPO gives no edge to serious cyclists, researchers claim
By Mardi Chapman
5 Jul 2017